Ganga Pharmaceuticals Ltd: ₹2.64 Cr Sales, ₹7 Cr Market Cap – Ayurveda Products, Allopathy P&L
Date of Publishing -
Spotted a factual error — a wrong number, date, or fact? Tell us and we will check the source.
1. At a Glance
If mummy puts asks you to apply Multani Mitti that money goes straight to Ganga Pharma, They make tablets, syrups, oils, gels, powders — and still reporting annual sales smaller than a Big Bazaar outlet’s weekend clearance. That’s Ganga Pharma. Market cap ₹7 Cr, revenues ₹2.64 Cr, and a P/E ratio of 88× — basically, Baba Ramdev’s Patanjali is playing IPL, and Ganga Pharma is still stuck in gully cricket.
2. Introduction
Ayurveda is India’s oldest export. From turmeric lattes in Starbucks to Ashwagandha gummies in California, the world loves our herbs. And yet, Ganga Pharma, born in 1989, hasn’t been able to capitalise.
Their product list looks impressive — 230+ items, 20+ patents, tablets for digestion, oils for hair, gels for skin, powders for everything from constipation to charisma. They even have OTC products like “Gangalax” (don’t ask), cosmetic powders, and traditional herbs like Shilajit and Triphala.
Presence? Maharashtra, Karnataka, Bengal, Odisha, and now e-commerce. But sales in FY25 = ₹2.64 Cr. That’s not “pharma,” that’s “local chemist ki monthly billings.”
So what’s the story? Ayurveda brand with massive product portfolio, but no distribution muscle. It’s like inventing the recipe for biryani and then selling it only in your gali.
3. Business Model (WTF Do They Even Do?)
Ganga Pharma is basically a boutique Ayurveda maker:
Products: GMP-certified 230+ SKUs across OTC, cosmetics, and traditional medicines.
Manufacturing: Facility at Virar, Palghar.
Distribution: Direct marketing + e-commerce + regional reach.
Revenue Model: 92% from sales of goods, 8% from interest on deposits. (Yes, interest income is almost keeping them alive.)
So the business model = “Sell Ayurvedic products if someone buys, else rely on FD interest.”
